https://www.selleckchem.com/pr....oducts/seclidemstat.
Oncogenic gene rearrangements have been exponentially significant for clinical management of cancer, from diagnosis to therapy and disease monitoring. Testing algorithms should be created with caution, and sample type, accessibility to testing method, turnaround time, and economic aspects should be taken into consideration. Herein, different molecular technologies for detecting these gene rearrangements are discussed and the benefits and limitations of each method are highlighted.Because the clinical impact of cancer genomics is be
Like
Comment
Share
